Table 2.
Levels of ICG enhancement before (day 0, baseline) and after (day 7) therapy with iloprost or alprostadil.
| Iloprost group | Alprostadil group | Total group | |
|---|---|---|---|
| (n = 16) | (n = 5) | (n = 21) | |
| Total hand segments | Total hand segments | Total hand segments | |
| Mean ± SD | Mean ± SD | Mean ± SD | |
| Day 0 (baseline) |
166 10.4 ± 7.4 |
85 17.0 ± 9.8 |
251 12.0 ± 8.3 |
|
| |||
| Day 7 | 98 6.1 ± 4.9 |
64 12.8 ± 6.8 |
162 7.7 ± 5.9 |
|
| |||
|
Relative reduction in %
Significance |
40.9% p < 0.05 |
24.7% p < 0.05 |
35.5% p < 0.05 |
Note: SD: standard deviation.